Skip to Content

46 Results Found

  • Article
  • Open Access
1 Citations
787 Views
14 Pages

Prognostic Value of the SUVmax–IPI Composite Score on Overall Survival in Metastatic Prostate Cancer

  • Emine Türkmen,
  • Atike Pınar Erdoğan,
  • Mustafa Şahbazlar,
  • Gözde Mütevelizade and
  • Ferhat Ekinci

31 March 2026

Objective: This study aimed to evaluate the prognostic value of the SUVmax–IPI composite score, generated by integrating the maximum standardized uptake value (SUVmax) derived from metastatic 68Ga-PSMA PET/CT imaging with the inflammatory progn...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
583 Views
17 Pages

The Association Between the STOP-Bang Score and the Integrated Pulmonary Index in Patients Undergoing Endobronchial Ultrasound with Sedation: The STOP OSA-IPI Cohort Study

  • Umran Ozden Sertcelik,
  • Mustafa Turker,
  • Ahmet Sertcelik,
  • Ebru Sengul Parlak and ,
  • Habibe Hezer,
  • Kubra Gungor,
  • Mithat Temizer,
  • Seyhan Yagar and
  • Aysegul Karalezli
  • + 4 authors+ 0 author

26 May 2026

Background and Perspectives: Obstructive sleep apnea (OSA) is a prevalent condition associated with increased perioperative risks. Endobronchial ultrasound (EBUS), a diagnostic and staging procedure requiring deep sedation, may pose additional risks...

(This article belongs to the Section Pulmonology)
  • Article
  • Open Access
354 Views
20 Pages

Predicting Primary Refractory Diffuse Large B-Cell Lymphoma: A Comparison of Machine Learning Models with the IPI Score

  • Cosmin-Daniel Minciuna,
  • Dorina Minciuna,
  • Ingrid-Andrada Vasilache and
  • Lucian Miron

27 August 2026

Background/Objectives: Diffuse large B-cell lymphoma (DLBCL) remains clinically heterogeneous despite standard first-line immunochemotherapy. We evaluated whether machine learning (ML) models using routinely available diagnostic variables could predi...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
1 Citations
7,108 Views
13 Pages

High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements are known for their aggressive clinical course and so are the ones with MYC and BCL2 protein overexpression. The optimal therapy for these lymphomas remains to be elucidated. A...

(This article belongs to the Special Issue Recent Advances in Lymphoma)
  • Article
  • Open Access
1 Citations
725 Views
15 Pages

21 February 2026

Introduction: Central nervous system (CNS) involvement is reported to represent 5% of extranodal diffuse large B cell lymphoma (DLBCL) at diagnosis. To stratify patients’ risk of CNS involvement, the CNS-International Prognostic Index (CNS-IPI)...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
1,455 Views
15 Pages

Nivolumab Plus Ipilimumab for Unresectable Hepatocellular Carcinoma in Early Real-World Clinical Practice: A Multicenter Analysis of Efficacy and Safety

  • Hironao Okubo,
  • Teppei Matsui,
  • Makoto Chuma,
  • Akihiro Funaoka and ,
  • Haruki Uojima,
  • Satoshi Narahara,
  • Masahiro Kobayashi,
  • Yuwa Ando,
  • Tsunamasa Watanabe and
  • Manabu Morimoto
  • + 15 authors+ 10 authors

20 August 2026

Background/Objectives: To investigate early treatment outcomes, including tumor response, predictors of response, and safety of nivolumab plus ipilimumab (Nivo/Ipi) therapy for unresectable hepatocellular carcinoma (uHCC) in a multicenter setting. Me...

(This article belongs to the Special Issue Hepatocellular Carcinoma: Clinical Evidence and Emerging Therapeutic Benefits)
  • Article
  • Open Access
94 Views
13 Pages

Inflammatory Prognostic Index Is Associated with the Presence and Severity of Hyperemesis Gravidarum

  • Erkan Göl,
  • Nuray Keskin,
  • İlke Esin Aydıner,
  • Dilara Kapusuz and ,
  • Tuana Dündar and
  • Keziban Doğan
  • + 1 author+ 0 author

14 November 2026

Background/Objectives: Hyperemesis gravidarum (HEG) has been associated with systemic inflammation, but blood-count-derived markers have shown only modest diagnostic value. We evaluated the inflammatory prognostic index (IPI), which combines the C-re...

(This article belongs to the Section Molecular and Translational Medicine)
  • Article
  • Open Access
11 Citations
3,995 Views
8 Pages

26 January 2021

Objective: To investigate the effect of parity and interpregnancy interval (IPI) on perinatal outcomes in advanced maternal age (AMA) parturients. Methods: A population-based retrospective cohort study of all women older than 40 years, who had a sing...

(This article belongs to the Special Issue Clinical Diagnosis and Management of Pregnancy Complications)
  • Article
  • Open Access
7 Citations
3,572 Views
17 Pages

Infection Probability Index: Implementation of an Automated Chronic Wound Infection Marker

  • Franziska Schollemann,
  • Janosch Kunczik,
  • Henriette Dohmeier,
  • Carina Barbosa Pereira and ,
  • Andreas Follmann and
  • Michael Czaplik
  • + 1 author+ 0 author

29 December 2021

The number of people suffering from chronic wounds is increasing due to demographic changes and the global epidemics of obesity and diabetes. Innovative imaging techniques within the field of chronic wound diagnostics are required to improve wound ca...

(This article belongs to the Special Issue Chronic Wounds or Hard to Heal Ulcers: Updating Epidemiology, Physiopathology, and Therapies)
  • Review
  • Open Access
8 Citations
4,898 Views
12 Pages

Association between Intestinal Parasite Infections and Proxies for Body Composition: A Scoping Review

  • Idalécia Cossa-Moiane,
  • Clémentine Roucher,
  • Tamlyn Mac Quene,
  • Maiza Campos-Ponce and ,
  • Nilsa de Deus,
  • Katja Polman and
  • Colleen Doak
  • + 2 authors+ 0 author

26 May 2022

It has long been recognized that intestinal parasite infections and undernutrition are closely linked. However, little is known about the role of intestinal parasite infections (IPIs), or parasite clearance, in these processes. The aim of this scopin...

(This article belongs to the Special Issue Nutrition, Physical Activity Interventions for Children Immunity Development)
  • Article
  • Open Access
15 Citations
3,782 Views
18 Pages

Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study

  • Umberto Basso,
  • Federico Paolieri,
  • Mimma Rizzo,
  • Ugo De Giorgi and ,
  • Sergio Bracarda,
  • Lorenzo Antonuzzo,
  • Francesco Atzori,
  • Giacomo Cartenì,
  • Giuseppe Procopio and
  • Giampaolo Tortora
  • + 16 authors+ 11 authors

4 May 2022

This is a retrospective analysis on the safety and activity of compassionate Ipilimumab and Nivolumab (IPI-NIVO) administered to patients with metastatic Renal Cell Carcinoma (mRCC) with intermediate or poor International Metastatic RCC Database Cons...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
2 Citations
3,441 Views
21 Pages

Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade

  • Jiayu Yang,
  • Lin Yang,
  • Bryan Tordon,
  • Oliver Bucher and ,
  • Zoann Nugent,
  • Ivan Landego,
  • Nicole Bourrier,
  • Kelsey Uminski,
  • Kevin Brown and
  • Versha Banerji
  • + 14 authors+ 9 authors

5 July 2023

FISH cytogenetics, TP53 sequencing, and IGHV mutational status are increasingly used as prognostic and predictive markers in chronic lymphocytic leukemia (CLL), particularly as components of the CLL International Prognostic Index (CLL-IPI) and in dir...

(This article belongs to the Topic Myeloma and Leukemia-Challenges and Current Treatment Options)
  • Article
  • Open Access
5,169 Views
13 Pages

Ultrasound-Guided Interphalangeal Injection (US-IPI) of Mucoid Cysts as a Non-Surgical Option: Technical Notes and Clinical Efficacy

  • Eliodoro Faiella,
  • Elva Vergantino,
  • Domiziana Santucci,
  • Amalia Bruno and ,
  • Giuseppina Pacella,
  • Vincenzo Panasiti,
  • Bruno Beomonte Zobel and
  • Rosario Francesco Grasso
  • + 3 authors+ 0 author

Digital mucous cysts (DMCs) are common soft tissue tumors affecting interphalangeal joints. Various treatment options exist, with surgical excision being the standard. Ultrasound-guided cortisone (CC) injection into the distal interphalangeal (DIP) j...

  • Article
  • Open Access
13 Citations
5,297 Views
13 Pages

Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia

  • Joerg Hoffmann,
  • Semil Eminovic,
  • Christian Wilhelm,
  • Stefan W. Krause and ,
  • Andreas Neubauer,
  • Michael C. Thrun,
  • Alfred Ultsch and
  • Cornelia Brendel
  • + 3 authors+ 0 author

4 February 2023

Background: The International Prognostic Index (IPI) is applied to predict the outcome of chronic lymphocytic leukemia (CLL) with five prognostic factors, including genetic analysis. We investigated whether multiparameter flow cytometry (MPFC) data o...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
1 Citations
2,510 Views
22 Pages

Development and Validation of Prognostic Models for Treatment Response of Patients with B-Cell Lymphoma: Standard Statistical and Machine-Learning Approaches

  • Adugnaw Zeleke Alem,
  • Itismita Mohanty,
  • Nalini Pati,
  • Cameron Wellard and ,
  • Eliza Chung,
  • Eliza A. Hawkes,
  • Zoe K. McQuilten,
  • Erica M. Wood,
  • Stephen Opat and
  • Theophile Niyonsenga
  • + 5 authors+ 0 author

21 October 2025

Background: Achieving a complete response after therapy is an important predictor of long-term survival in lymphoma patients. However, previous predictive models have primarily focused on overall survival (OS) and progression-free survival (PFS), oft...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
347 Views
17 Pages

Is There a Tumor Proportion Score Threshold at Which Tumor-Cell PD-L1 Adds Prognostic Information Beyond the International Prognostic Index in Large B-Cell Lymphoma?

  • Mehmet Mutlu Kidi,
  • Suheda Atas Ipek,
  • Sendag Yaslikaya,
  • Mahmut Buyuksimsek and ,
  • Mehmet Turker,
  • Yasemin Aydinalp Camadan,
  • Sedat Biter,
  • Tolga Koseci,
  • Tugba Toyran and
  • Ertugrul Bayram
  • + 8 authors+ 3 authors

19 September 2026

Background/Objectives: In diffuse large B-cell lymphoma (DLBCL), the prognostic value of programmed death-ligand 1 (PD-L1) depends on the immunohistochemical threshold applied. We asked whether tumor-cell PD-L1 adds prognostic information beyond the...

(This article belongs to the Special Issue Novel Biomarkers for Clinical Diagnosis and Prognosis)
  • Commentary
  • Open Access
3 Citations
1,752 Views
9 Pages

24 December 2024

Background/Objectives: Diffuse large B-cell lymphoma (DLBCL) and high-grade B cell lymphoma (HGBL) comprise the majority of large B-cell lymphomas (LBCL), and approximately two-thirds of patients diagnosed with these LBCLs are cured following treatme...

(This article belongs to the Special Issue Advances in B-Cell Lymphoma: From Diagnostics to Cure)
  • Article
  • Open Access
2 Citations
3,142 Views
16 Pages

Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial

  • Sara Fernández-Castillejo,
  • Joan Badia,
  • Luís de la Cruz-Merino,
  • Alejandro Martín Garcia-Sáncho and ,
  • Fernando Carnicero-González,
  • Natalia Palazón-Carrión,
  • Eduardo Ríos-Herranz,
  • Fátima de la Cruz-Vicente,
  • Antonio Rueda-Domínguez and
  • Josep Gumà
  • + 21 authors+ 16 authors

5 February 2025

Background: Patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are ineligible for high-dose chemotherapy have limited treatment options and poor life expectancy. The purpose of this study is to identify a serum metab...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
6 Citations
2,563 Views
14 Pages

Thromboinflammatory Biomarkers in Lymphomas: Linking Inflammation to Thrombosis Risk

  • Emilija Živković,
  • Olivera Mitrović-Ajtić,
  • Tijana Subotički,
  • Jelena Ivanović and ,
  • Vladimir Otašević,
  • Dragoslava Đikić,
  • Miloš Diklić,
  • Milica Vukotić,
  • Teodora Dragojević and
  • Vladan P. Čokić
  • + 7 authors+ 2 authors

26 February 2025

Thrombosis is a critical complication in lymphomas, driven by chronic inflammation. To observe this systemic mechanism, we evaluated inflammatory cytokines, neutrophil and monocyte activation, and platelet function in diffuse large B-cell lymphoma (D...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
758 Views
20 Pages

Prognostic Value of Semi-Quantitative Metabolic Parameters on [18F]FDG PET/CT in Patients with Diffuse Large B-Cell Lymphoma at Diagnosis

  • Emanuele Cencini,
  • Federica Orsini,
  • Marta Franceschini,
  • Sara Fredducci and ,
  • Mattia Bello,
  • Emanuele Pacini,
  • Marcello Bradaschia,
  • Anna Sicuranza,
  • Chiara Carrara and
  • Alberto Fabbri
  • + 7 authors+ 2 authors

After first-line therapy with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), 20–30% of patients with diffuse large B-cell lymphoma (DLBCL) have relapsed or refractory disease. Semi-quantitative volume parameters...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
4 Citations
2,440 Views
11 Pages

Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors

  • Sara Mokbel,
  • Giuilia Baciarello,
  • Pernelle Lavaud,
  • Aurelius Omlin and ,
  • Fabio Calabrò,
  • Richard Cathomas,
  • Stefanie Aeppli,
  • Pauline Parent,
  • Patrizia Giannatempo and
  • Anna Patrikidou
  • + 17 authors+ 12 authors

11 April 2024

Background: Immune checkpoint inhibitors (ICIs) improve overall survival (OS) in advanced/metastatic urothelial cancer (a/mUC) patients. Preliminary evidence suggests a prognostic role of inflammatory biomarkers in this setting. We aimed to develop a...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
3 Citations
976 Views
17 Pages

Nutrition-Related Indices and Systemic Inflammation in Acute Coronary Syndrome: Prognostic Utility of PNI with IPI/AISI and Links to Angiographic Severity and Survival

  • Nedim Uzun,
  • Naile Fevziye Misirlioglu,
  • Seyma Dumur,
  • Sinem Durmus and ,
  • Aysun Ekinci and
  • Hafize Uzun
  • + 1 author+ 0 author

19 March 2026

Background: Acute coronary syndrome (ACS) remains a leading cause of morbidity and mortality worldwide, and improved risk stratification beyond conventional biomarkers is needed. Novel laboratory-derived indices reflecting systemic inflammation and i...

(This article belongs to the Section Nutritional Epidemiology)
  • Article
  • Open Access
115 Citations
9,174 Views
15 Pages

Contamination and Health Risk Assessment of Heavy Metals in the Soil of Major Cities in Mongolia

  • Sonomdagva Chonokhuu,
  • Chultem Batbold,
  • Byambatseren Chuluunpurev,
  • Enkhchimeg Battsengel and ,
  • Batsuren Dorjsuren and
  • Batdelger Byambaa
  • + 1 author+ 0 author

Using the case of Ulaanbaatar, Erdenet, and Darkhan cities from Mongolia, the study aimed to assess the contamination level and health risk assessment of heavy metals (As, Cr, Pb, Ni, and Zn) in urban soil. A total of 78 samples was collected from a...

(This article belongs to the Special Issue Heavy Metal Pollution and Health Risk Assessment)
  • Article
  • Open Access
7 Citations
3,689 Views
19 Pages

Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements

  • Vito Olschewski,
  • Hanno M. Witte,
  • Veronica Bernard,
  • Konrad Steinestel and ,
  • Wolfgang Peter,
  • Hartmut Merz,
  • Johannes Rieken,
  • Harald Biersack,
  • Nikolas von Bubnoff and
  • Niklas Gebauer
  • + 6 authors+ 1 author

20 February 2021

High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements (double/triple-hit high grade B-cell lymphoma, HGBL-DH/TH) constitutes a provisional entity among B-cell malignancies with an aggressive behavior and dire prognosis. While evide...

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
352 Views
17 Pages

Plasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

  • Vibor Milunović,
  • Maja Pučić-Baković,
  • Frano Vučković,
  • Ivana Duvnjak-Orešković and ,
  • Karla Mišura Jakobac,
  • Marin Kursar,
  • Inga Mandac Smoljanović,
  • Delfa Radić-Krišto and
  • Slavko Gašparov
  • + 4 authors+ 0 author

23 September 2026

Background: Diffuse large B-cell lymphoma (DLBCL) is a biologically heterogeneous lymphoma with variable clinical outcomes despite established molecular and clinical prognostic models. Immunoglobulin G (IgG) N-glycosylation regulates antibody effecto...

(This article belongs to the Special Issue Lymphomas: From Mechanisms to Therapeutic Approaches)
  • Article
  • Open Access
851 Views
19 Pages

Clinical, Biological, and Treatment-Related Predictors of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study

  • Cosmin-Daniel Minciuna,
  • Dorina Minciuna,
  • Angela-Smaranda Dascalescu,
  • Amalia Titieanu and ,
  • Vlad-Andrei Cianga,
  • Ion Antohe,
  • Ingrid-Andrada Vasilache,
  • Catalin-Doru Danaila and
  • Lucian Miron
  • + 4 authors+ 0 author

9 April 2026

Background/Objectives: Central Nervous System (CNS) relapse represents a severe and often fatal complication of Diffuse Large B-Cell Lymphoma (DLBCL). This study aimed to evaluate clinical, biological, and treatment-related factors associated with pr...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
4 Citations
2,678 Views
13 Pages

The Impact of Segmentation Method and Target Lesion Selection on Radiomic Analysis of 18F-FDG PET Images in Diffuse Large B-Cell Lymphoma

  • Francesca Botta,
  • Mahila Ferrari,
  • Sara Raimondi,
  • Federica Corso and ,
  • Giuliana Lo Presti,
  • Saveria Mazzara,
  • Lighea Simona Airò Farulla,
  • Tommaso Radice,
  • Anna Vanazzi and
  • Francesco Ceci
  • + 7 authors+ 2 authors

27 September 2022

Radiomic analysis of 18F[FDG] PET/CT images might identify predictive imaging biomarkers, however, the reproducibility of this quantitative approach might depend on the methodology adopted for image analysis. This retrospective study investigates the...

(This article belongs to the Section Applied Biosciences and Bioengineering)
  • Article
  • Open Access
533 Views
14 Pages

Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma

  • Tahir Alper Cinli,
  • Gökhan Burul,
  • Hasan Göze,
  • Mesut Ayer and
  • Istemi Serin

17 June 2026

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma. Despite advances in immunochemotherapy, approximately 30–40% of patients experience relapsed or refractory disease. Nutritional and inflammato...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
4 Citations
1,259 Views
24 Pages

Prognostic Value of the CALLY Index in Diffuse Large B-Cell Lymphoma: Linking Inflammation, Nutrition, and Tumor Biology

  • Zorica Cvetković,
  • Ilija Bukurecki,
  • Snežana Pejić,
  • Anica Divac Pravdić and ,
  • Miroslav Pavlović,
  • Vesna Vučić and
  • Olivera Marković
  • + 2 authors+ 0 author

5 March 2026

Background/Objectives: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma and remains incurable in approximately 30–40% of patients despite advances in immunochemotherapy. Although gene expression profiling...

(This article belongs to the Special Issue Diagnosis and Biomarkers for Hematologic Malignancies)
  • Article
  • Open Access
4 Citations
3,501 Views
14 Pages

Clinical Features, Phenotypic Markers and Outcomes of Diffuse Large B-Cell Lymphoma between HIV-Infected and HIV-Uninfected Chinese Patients

  • Minghan Zhou,
  • Jinlin Cheng,
  • Handan Zhao,
  • Min Yang and ,
  • Wenjuan Yu,
  • Jiaying Qin,
  • Guanjing Lang,
  • Ran Tao,
  • Qing Cao and
  • Lijun Xu
  • + 7 authors+ 2 authors

31 October 2022

Background: The effect of HIV infection on the clinicopathological characteristics of diffuse large B-cell lymphoma (DLBCL) remains debatable. Methods: Fifty-three HIV-infected and ninety-three HIV-uninfected DLBCL patients were enrolled in the retro...

  • Review
  • Open Access
25 Citations
4,931 Views
20 Pages

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct

  • Isabel González-Gascón-y-Marín,
  • Carolina Muñoz-Novas,
  • Ana-Eugenia Rodríguez-Vicente,
  • Miguel Quijada-Álamo and ,
  • María Hernández-Sánchez,
  • Claudia Pérez-Carretero,
  • Victoria Ramos-Ascanio and
  • José-Ángel Hernández-Rivas
  • + 3 authors+ 0 author

8 April 2021

Chronic lymphocytic leukemia (CLL) is an extremely heterogeneous disease. With the advent of oral targeted agents (Tas) the treatment of CLL has undergone a revolution, which has been accompanied by an improvement in patient’s survival and quality of...

(This article belongs to the Special Issue Bio-Pathological Markers in the Diagnosis and Therapy of Cancer)
  • Review
  • Open Access
7 Citations
3,612 Views
12 Pages

The Role of Geriatric Assessment in the Management of Diffuse Large B-Cell Lymphoma

  • Francesco Merli,
  • Stefano Pozzi,
  • Hillary Catellani,
  • Emiliano Barbieri and
  • Stefano Luminari

14 December 2023

The treatment choice for an older patient with diffuse large B-cell lymphoma (DLBCL) depends on many other factors in addition to age, which alone does not reflect the complexity of the aging process. Functional features and comorbidity incidence dif...

(This article belongs to the Special Issue Recent Research of Geriatric Hematology)
  • Article
  • Open Access
19 Citations
8,115 Views
16 Pages

Primary Gastrointestinal T/NK Cell Lymphoma

  • Eun Kyung Kim,
  • Mi Jang,
  • Woo Ick Yang and
  • Sun Och Yoon

29 May 2021

Primary gastrointestinal T/NK cell lymphoma (GI-TNKL) is an uncommon and heterogeneous group of lymphoid malignancies. We aimed to investigate their subtype distribution, clinicopathologic characteristics, and clinical outcomes. A total of 38 GI-TNKL...

  • Case Report
  • Open Access
1 Citations
2,803 Views
9 Pages

Complications of Brentuximab Therapy in Patients with Hodgkin’s Lymphoma and Concurrent Autoimmune Pathology—A Case Series

  • Oana Diana Preda,
  • Sorina Bădeliță,
  • Iulia Ursuleac,
  • Ruxandra Maria Irimia and ,
  • Sonia Balanica,
  • Monica Cojocaru,
  • Cristina Cotruta,
  • Camelia Dobrea and
  • Daniel Coriu
  • + 4 authors+ 0 author

Background: Brentuximab Vedotin (BV) has revolutionized the treatment landscape for Hodgkin’s lymphoma, yet its effects on pre-existing autoimmune disorders remain elusive. Methods: Here, we present four cases of patients with concurrent autoim...

  • Article
  • Open Access
4 Citations
3,755 Views
15 Pages

Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement

  • Mélanie Mercier,
  • Corentin Orvain,
  • Laurianne Drieu La Rochelle,
  • Tony Marchand and ,
  • Christopher Nunes Gomes,
  • Aurélien Giltat,
  • Jérôme Paillassa,
  • Aline Clavert,
  • Jonathan Farhi and
  • Mathilde Hunault-Berger
  • + 9 authors+ 4 authors

12 June 2021

Diffuse large B-cell lymphoma (DLBCL) with extra nodal skeletal involvement is rare. It is currently unclear whether these lymphomas should be treated in the same manner as those without skeletal involvement. We retrospectively analyzed the impact of...

  • Article
  • Open Access
8 Citations
4,607 Views
14 Pages

Comparison of Ki67 Proliferation Index in Gastrointestinal Non-Hodgkin Large B-Cell Lymphomas: The Conventional Method of Evaluation or AI Evaluation?

  • Miruna Cristian,
  • Mariana Așchie,
  • Mariana Deacu,
  • Mădălina Boșoteanu and ,
  • Gabriela Izabela Bălțătescu,
  • Andreea Georgiana Stoica,
  • Anca Antonela Nicolau,
  • Ionuț Poinăreanu and
  • Cristian Ionuț Orășanu
  • + 4 authors+ 0 author

27 August 2023

The most common NHL subtype in SEEU is DLBCL (39%), and it manifests with a variety of cellular morphologies and a high proliferation index. Also, the GI tract is the most common site of extranodal NHLs, and most NHLs involving the GI tract are of B-...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
5 Citations
3,155 Views
16 Pages

Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France

  • Marguerite Kandel,
  • Aurélie Bardet,
  • Stéphane Dalle,
  • Clara Allayous and ,
  • Laurent Mortier,
  • Bernard Guillot,
  • Caroline Dutriaux,
  • Marie-Thérèse Leccia,
  • Sophie Dalac and
  • Isabelle Borget
  • + 22 authors+ 17 authors

27 November 2022

Nine drugs have been marketed for 10 years for the treatment of advanced melanoma (AM). With half of patients reaching a second line, the optimal sequence of treatments remains unclear. To inform policy-makers about their efficiency, we performed a c...

  • Article
  • Open Access
3 Citations
2,185 Views
14 Pages

Clinical Implication of Sequential Circulating Tumor DNA Assessments for the Treatment of Diffuse Large B-Cell Lymphoma

  • Ga-Young Song,
  • Joo Heon Park,
  • Sae-Ryung Kang,
  • Seung Jung Han and ,
  • Youjin Jung,
  • Minuk Son,
  • Ho Cheol Jang,
  • Mihee Kim,
  • Seo-Yeon Ahn and
  • Deok-Hwan Yang
  • + 9 authors+ 4 authors

22 May 2025

Background/Objectives: Circulating tumor DNA (ctDNA) has emerged as a promising biomarker for non-invasive tumor monitoring in diffuse large B-cell lymphoma (DLBCL). Methods: In this study, 52 patients with newly diagnosed advanced-stage DLBCL treate...

(This article belongs to the Special Issue Advances in Pathology of Lymphoma and Leukemia)
  • Article
  • Open Access
4 Citations
3,432 Views
21 Pages

Non-Hodgkin lymphoma (NHL) is characterized by a great variability in patient outcomes, resulting in the critical need for identifying new molecular prognostic biomarkers. This study aimed to identify novel circulating prognostic biomarkers based on...

(This article belongs to the Special Issue Role of Non-coding RNAs in Cancer: Markers in Disease Progression and Therapeutics)
  • Article
  • Open Access
16 Citations
3,307 Views
13 Pages

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

  • Guido Bocci,
  • Sabrina Pelliccia,
  • Paola Orlandi,
  • Matteo Caridi and ,
  • Marta Banchi,
  • Gerardo Musuraca,
  • Arianna Di Napoli,
  • Maria Paola Bianchi,
  • Caterina Patti and
  • Maria Christina Cox
  • + 10 authors+ 5 authors

1 December 2022

The upfront treatment of very elderly and frail patients with diffuse large B-cell lymphoma (DLBCL) is still a matter of debate. Herein, we report results of the metronomic all-oral DEVEC [prednisolone/deltacortene®, vinorelbine (VNR), etoposide (ETO...

(This article belongs to the Special Issue Clinical Applications of Metronomic Chemotherapy)
  • Article
  • Open Access
1 Citations
2,120 Views
13 Pages

Primary Palatine Tonsil Non-Hodgkin Lymphoma in Western Romania: A Comparison of Lower-Stage and Advanced-Stage Disease

  • Raluca Morar,
  • Norberth-Istvan Varga,
  • Delia Ioana Horhat,
  • Ion Cristian Mot and ,
  • Nicolae Constantin Balica,
  • Alina-Andree Tischer,
  • Monica Susan,
  • Razvan Susan,
  • Diana Luisa Lighezan and
  • Rodica Anamaria Negrean
  • + 5 authors+ 0 author

Background: Limited data exist on primary palatine tonsil Non-Hodgkin lymphoma (NHL) from regions with constrained healthcare access. This study investigated this malignancy in Western and South-Western Romania, comparing lower-stage (Ann-Arbor I-III...

  • Article
  • Open Access
333 Views
13 Pages

Diagnosis-to-Treatment Interval Reflects Clinical Urgency and Disease Burden in T-Lymphoblastic Lymphoma: A Multicenter Cohort Study

  • Jin Chai,
  • Yunyan Sun,
  • Xuewen Lei,
  • Linjun Zhao and ,
  • Jie Chen,
  • Wenhui Zhang,
  • Yue Wang,
  • Ni An,
  • Lingyan Ping and
  • Hui Yu
  • + 6 authors+ 1 author

19 August 2026

Objective: Diagnosis-to-treatment interval (DTI) has been investigated in several lymphoma subtypes, but its significance in T-lymphoblastic lymphoma (T-LBL) remains unclear. We evaluated whether DTI reflects clinical urgency, disease burden and earl...

(This article belongs to the Special Issue Diagnosis and Clinical Management in Hematologic Oncology)
  • Article
  • Open Access
4 Citations
4,960 Views
17 Pages

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas

  • Ramón Diez-Feijóo,
  • Marcio Andrade-Campos,
  • Joan Gibert,
  • Blanca Sánchez-González and ,
  • Lierni Fernández-Ibarrondo,
  • Concepción Fernández-Rodríguez,
  • Nieves Garcia-Gisbert,
  • Laura Camacho,
  • Marta Lafuente and
  • Beatriz Bellosillo
  • + 8 authors+ 3 authors

11 January 2024

Background: Cell-free DNA (cfDNA) analysis has become a promising tool for the diagnosis, prognosis, and monitoring of lymphoma cases. Until now, research in this area has mainly focused on aggressive lymphomas, with scanty information from other lym...

(This article belongs to the Special Issue Current and Emerging Utility of Liquid Biopsy in Cancers. More than Surrogate Biomarkers)
  • Article
  • Open Access
48 Citations
4,177 Views
19 Pages

A modified mesenchymal stem cell (MSC) transplantation is a highly effective and precise treatment for inflammatory bowel disease (IBD), with a significant curative effect. Thus, we aim to examine the efficacy of hypoxia-inducible factor (HIF)–1α-ove...

(This article belongs to the Special Issue 10th Anniversary of Biomedicines—Advances in Mesenchymal Stem Cells)
  • Systematic Review
  • Open Access
909 Views
25 Pages

Background/Objectives: High-grade B-cell lymphomas (HGBCLs) with MYC and BCL2 or BCL6 translocations, colloquially referred to as double-hit lymphomas (and abbreviated here to DHL), are aggressive malignancies. Differentiating DHL from non-DHL HGBCLs...

(This article belongs to the Section Molecular and Translational Medicine)
  • Article
  • Open Access
3 Citations
856 Views
41 Pages

Background: Diffuse large B-cell lymphoma (DLBCL) is one of the most frequent lymphomas. To date, it is not possible to identify which DLBCL patients will have an aggressive clinical evolution only by using hematoxylin and eosin (H&E) histologica...

(This article belongs to the Topic The Tumor Microenvironment, Immuno-Oncology, and Immune Checkpoint: Implications for Current and Emergent Immunotherapies, 2nd Edition)